The modulation of IL-17 over the course of MM is consistent with the recent finding that the numbers of IL-17 producing TH17 cells are elevated in patients with active disease, but are restored to normal with treatment [45]. The gene discussed is IL17A; the disease is Miyoshi myopathy.